Page 63 - Human Use News Today

Aurobindo Pharma said it will work with the agency to re-submit the applications at the earliest and reiterated that the withdrawal will not impact any future filings or ongoing clinical studies as it is procedural in nature

(Alliance News) - Stocks in London were set to start the new week marginally lower, with financial markets unfazed by a failed revolt by a mercenary army in Russia over the weekend. Wagner mercenaries headed back to their base on Sunday after Russian P...

(Alliance News) - GSK PLC on Monday celebrated several regulatory approvals for new drug therapies, including treatments for shingles. The Japanese Ministry of Health, Labour & Welfare has approved an updated indication for Shingrix, the London-base...

A private-equity-backed owner decides to shut an autism care company, two people at a medical supply company are found guilty of fraud and more in today's Health Pulse.

) GSK receives positive CHMP opinion recommending authorisation of daprodustat for symptomatic anaemia associated with chronic kidney disease in adults on chronic maintenance dialysis GSK plc (LSE/NYSE: GSK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending authorisation of daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the treatment of symptomatic

GSK receives positive CHMP opinion recommending authorisation of daprodustat for symptomatic anaemia associated with chronic kidney disease in adults on chronic maintenance dialysis GSK plc (LSE/NYS...

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hi...

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

The Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has granted a positive opinion recommending Jardiance empagliflozin for the treatment of adults with chronic kidney disease CKD Boehringer Ingelheim and Eli Lilly and Company NYSE LLY announced today.1

By Adriano Marchese Shares of Amylyx Pharmaceuticals were down at midday on Friday after the biopharmaceutical company said its treatment for amytrophic...